Electrolyte disturbances in the intensive care unit.

abstract：:Elderly ESRD patients often lose functionality when they start dialysis, which may be due to a variety of clinical problems. We recently postulated that intensive (longer and/or more frequent) hemodialysis (HD) may be the ideal strategy to try to prevent these ESRD- and dialysis-related complications, including dialys...

journal_title：Seminars in dialysis

authors： Cornelis T,Kotanko P,Goffin E,van der Sande FM,Kooman JP,Chan CT

更新日期：2012-11-01 00:00:00

abstract：:Cardiac hypertrophy is a relatively common complication seen in patients with advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD). Moreover, cardiac hypertrophy is even more frequently seen in patients with ESRD who have an arteriovenous (AV) access. There has been substantial evidence pertaining ...

journal_title：Seminars in dialysis

authors： Duque JC,Gomez C,Tabbara M,Alfonso CE,Li X,Vazquez-Padron RI,Asif A,Lenz O,Briones PL,Salman LH

更新日期：2015-05-01 00:00:00

abstract：:Depression has been documented as the most frequently encountered psychological problem in end-stage renal disease (ESRD) patients and has been correlated with both mortality and morbidity in these patients. Previous work by our group has shown that clinical depression is treatable with psychotropic medications in the...

journal_title：Seminars in dialysis

authors： Wuerth D,Finkelstein SH,Kliger AS,Finkelstein FO

更新日期：2003-11-01 00:00:00

abstract：:Despite improvements in the delivery of care, the annual all-cause mortality rate for end-stage renal disease (ESRD) patients is still around 220 deaths per 1000 at risk patient-years. Infection-related causes are second only to cardiovascular events as a cause for mortality among ESRD patients. Almost two-thirds of a...

journal_title：Seminars in dialysis

authors： Camins BC

更新日期：2013-07-01 00:00:00

abstract：:Despite having thousands of blood pressure (BP) readings on individual dialysis patients over the course of a year, our knowledge about the optimal assessment of BP, the mechanisms underlying hypertension and its management remain incomplete. Observational studies reveal that BP is lower at home than when measured in ...

journal_title：Seminars in dialysis

authors： Miskulin DC,Weiner DE

更新日期：2017-05-01 00:00:00

abstract：:Parenteral iron is used to restore the body's iron pool before and during erythropoiesis-stimulating agent (ESA) therapy; together these agents form the backbone of anemia management in end-stage renal disease (ESRD) patients undergoing hemodialysis. ESRD patients receiving chronic intravenous iron products, which exc...

journal_title：Seminars in dialysis

authors： Rostoker G

更新日期：2019-01-01 00:00:00

abstract：:Peritoneal dialysis (PD) is a markedly underutilized modality for permanent renal replacement therapy in the United States owing to a low rate of patient referral and high rate of patient dropout or transfer to hemodialysis. One cause for patient loss from PD is problematic PD catheters that often are removed rather t...

journal_title：Seminars in dialysis

authors： Asif A,Gadalean F,Vieira CF,Hogan R,Leon C,Merrill D,Ellis R,Amador A,Broche O,Bush B,Contreras G,Pennell P

更新日期：2006-03-01 00:00:00

abstract：:Hypertension among patients on hemodialysis is common, difficult to diagnose and often inadequately controlled. Although specific blood pressure (BP) targets in this particular population are not yet established, meta-analyses of randomized trials showed that deliberate BP-lowering with antihypertensive drugs improves...

journal_title：Seminars in dialysis

authors： Georgianos PI,Agarwal R

更新日期：2018-11-01 00:00:00

abstract：:The development of pleural effusions in ESRD patients is a relatively common occurrence. Uremia, currently a rare cause of effusion, can lead to the development of hemorrhagic pleural fluid collections in patients who are underdialyzed. Uremic pleural effusions should be considered when common etiologies of effusions ...

journal_title：Seminars in dialysis

authors： Krishnan M,Choi M

更新日期：2001-05-01 00:00:00

abstract：:Arteriovenous fistula (AVF) nonmaturation is currently a significant clinical problem; however, the mechanisms responsible for this have remained unanswered. Previous work by our group and others has suggested that anatomical configuration and the corresponding hemodynamic endpoints could have an important role in AVF...

journal_title：Seminars in dialysis

authors： Rajabi-Jagahrgh E,Krishnamoorthy MK,Roy-Chaudhury P,Succop P,Wang Y,Choe A,Banerjee RK

更新日期：2013-03-01 00:00:00

abstract：:Translumbar tunneled dialysis catheter (TLDC) is a temporary dialysis access for patients exhausted traditional access for dialysis. While few small studies reported successes with TLDC, additional studies are warranted to understand the short- and long-term patency and safety of TLDC. We conducted a retrospective ana...

journal_title：Seminars in dialysis

authors： Liu F,Bennett S,Arrigain S,Schold J,Heyka R,McLennan G,Navaneethan SD

更新日期：2015-07-01 00:00:00

abstract：:In this article we deal with three aspects of acidosis in patients with chronic renal insufficiency: clinical characteristics, pathophysiology, and therapeutic approach. ...

journal_title：Seminars in dialysis

authors： Uribarri J

更新日期：2000-07-01 00:00:00

abstract：:Extracorporeal elimination of drugs and toxins is a critical component in the management of poisonings, though specific techniques and indications remain a matter of debate. Conventional hemodialysis is frequently the treatment of choice because of its widespread availability and proven effectiveness for certain drugs...

journal_title：Seminars in dialysis

authors： Goodman JW,Goldfarb DS

更新日期：2006-09-01 00:00:00

abstract：:This review aims to summarize the available evidence of the effectiveness of oral iron in patients receiving dialysis. Four small randomized controlled trials (105 evaluated patients) compared oral iron supplements with placebo or no treatment; hemoglobin and ferritin levels did not differ significantly between groups...

journal_title：Seminars in dialysis

authors： Hodson EM,Craig JC

更新日期：2014-01-01 00:00:00

abstract：:Universal lower dialysate [Na+] is often advocated as a means of improving the dire cardiovascular plight of our dialysis patients. However, there is evidence associating lower dialysate [Na+] and increased morbidity and mortality especially in frailer patients, probably as a result of more frequent intra-dialytic hyp...

journal_title：Seminars in dialysis

authors： Marshall MR,Dunlop JL

更新日期：2012-05-01 00:00:00

abstract：:Measurements of the concentration of parathyroid hormone (PTH) in serum or plasma are used widely for the initial diagnostic assessment of patients with renal bone disease, to monitor disease progression, and to gauge responses to treatment. Several analytical methods are used to measure plasma PTH levels, and a varie...

journal_title：Seminars in dialysis

authors： Goodman WG

更新日期：2007-01-01 00:00:00

abstract：:Managing an end-stage renal disease (ESRD) patient is complex and presents many ethical challenges for the physician. Ownership of dialysis facilities has shifted over the past decade from largely nonprofit organizations to large companies whose shareholders are primarily interested in the profitability of their inves...

journal_title：Seminars in dialysis

authors： Bennett WM

更新日期：2004-01-01 00:00:00

abstract：:The aim of this study was to describe the range and extent of current procedural practices of Nephrologists and trainees in Australia and New Zealand with a specific focus on renal biopsy. A web-based survey was constructed based on a 2009 pilot survey conducted by the authors. The survey was distributed by email. A t...

journal_title：Seminars in dialysis

authors： Ritchie AG,Saunders J,Baer R,May S,Australian and New Zealand Special Interest Group in Interventional Nephrology Research Collaboration.

更新日期：2013-11-01 00:00:00

abstract：:As suggested by its American brand name (Sensipar), the calcimimetic cinacalcet sensitizes the parathyroid cells to the extracellular calcium signal, suppressing parathyroid hormone (PTH) release and synthesis and preventing parathyroid cell proliferation. This primary PTH suppression decreases the release of calcium ...

journal_title：Seminars in dialysis

authors： Shahapuni I,Mansour J,Harbouche L,Maouad B,Benyahia M,Rahmouni K,Oprisiu R,Bonne JF,Monge M,El Esper N,Presne C,Moriniere P,Choukroun G,Fournier A

更新日期：2005-05-01 00:00:00

abstract：:We present a case of arteriovenous graft pseudoaneurysms treated endovascularly with stent grafts and make suggestions regarding the technique of evaluating the pseudoaneurysms and choosing the proper location to deploy the stent grafts to maximize the outcomes and minimize the length of the graft covered by the stent...

journal_title：Seminars in dialysis

authors： Florescu MC,Fillaus JA,Plumb TJ

更新日期：2014-03-01 00:00:00

abstract：:This report reviews the most common surgical interventions and complications of chronic peritoneal dialysis (PD) patients. Based on the current knowledge as well as our experience we detail the role of these surgical procedures. We supplement the reported knowledge in the field with our own experience in this area. Th...

journal_title：Seminars in dialysis

authors： Ratajczak A,Lange-Ratajczak M,Bobkiewicz A,Studniarek A

更新日期：2017-01-01 00:00:00

abstract：:There has been a dramatic, worldwide expansion in life expectancy across the last century. This has resulted in a progressively more elderly and comorbid population. It is increasingly recognized that healthcare in this group needs to move to the concept of "adding life to years". Recognition and assessment of frailty...

journal_title：Seminars in dialysis

authors： Corbett RW,Brown EA

更新日期：2018-11-01 00:00:00

abstract：:Dialysis remains the predominant form of renal replacement therapy in the United States, but the optimal timing for the initiation of dialysis remains poorly defined. Not only clinical factors such as signs/symptoms of uremia, co-existing cardiovascular disease, and presence of diabetes but also key demographic charac...

journal_title：Seminars in dialysis

authors： Streja E,Nicholas SB,Norris KC

更新日期：2013-11-01 00:00:00

abstract：:Cardiovascular complications are the leading cause of mortality in patients with end-stage renal disease (ESRD). The excess cardiovascular risk and mortality is already demonstrable in early renal disease and in patients with chronic renal failure (CRF), with the highest relative risk of mortality in the youngest pati...

journal_title：Seminars in dialysis

authors： London GM

更新日期：2003-03-01 00:00:00

abstract：:Patients on chronic hemodialysis have a shortened survival compared to the general population. There are multiple sources of morbidity and mortality unique to the dialysis population that account for this. Reasons include the effects of blood membrane interactions, intradialytic hypotension, myocardial stunning, exces...

journal_title：Seminars in dialysis

authors： Stegmayr BG

更新日期：2016-11-01 00:00:00

abstract：:While patients with sickle cell disease currently constitute a very small minority of the US dialysis population (0.1%), there is anticipated growth of this group as the life expectancy of those with sickle cell disease (SCD) increases. SCD patients suffer a high burden of morbidity, which is enhanced by the presence ...

journal_title：Seminars in dialysis

authors： Boyle SM,Jacobs B,Sayani FA,Hoffman B

更新日期：2016-01-01 00:00:00

abstract：:Nephrologists offer renal replacement therapy (RRT) to patients who are unlikely to benefit in part because of our discomfort discussing goals of care in the setting of an uncertain prognosis for a given individual. Permanent neurological impairment, terminal illness (life expectancy <6 months), medical conditions pre...

journal_title：Seminars in dialysis

authors： Holley JL

更新日期：2016-07-01 00:00:00

abstract：:Although many nephrologists see value in maximizing clearance and time on dialysis, clinical trials have failed to show a clear and consistent benefit of increasing clearance above the minimum threshold level recommended in clinical practice guidelines or of increasing dialysis session length or frequency. Available e...

journal_title：Seminars in dialysis

authors： O'Hare AM

更新日期：2020-11-01 00:00:00

abstract：:The specialty of Nephrology, by virtue of its relationship with the dialysis procedure, is highly vulnerable to litigation. As is the case with all nephrologists, a dialysis unit medical director is not immune to medical malpractice suits, and can be held liable for any act of perceived or potential harm to any dialys...

journal_title：Seminars in dialysis

authors： Vaqar S,Murray B,Panesar M

更新日期：2014-09-01 00:00:00

abstract：:Hyperkalemia is common in patients with end-stage renal disease, and may result in serious electrocardiographic abnormalities. Dialysis is the definitive treatment of hyperkalemia in these patients. Intravenous calcium is used to stabilize the myocardium. Intravenous insulin and nebulized albuterol lower serum potassi...

journal_title：Seminars in dialysis

authors： Putcha N,Allon M

更新日期：2007-09-01 00:00:00